Metacognitive Reflection & Insight Therapy (MERIT)

Metacognitive Reflection & Insight Therapy (MERIT): a randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN16659871

Enrollment

Registered

2013-03-20

Start date

2013-05-01

Completion date

Unknown

Last updated

2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia, metacognitive deficits Mental and Behavioural Disorders Schizophrenia, unspecified

Interventions

The treatment condition will receive the Metacognitive Reflection and Insight Therapy (MERIT). This psychotherapy seeks to enhance the metacognitive abilities of people with schizophrenia and is devel

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. A diagnosis of schizophrenia according to Diagnostic and Statistical Manual of Mental Disorders, 4th edition text revision (DSM-IV-TR) criteria 2. Impaired metacognitive skills 3. Being able to give informed consent 4. Men and women,18- 65 years old 5. No change in medication in the past thirty days

Exclusion criteria

Exclusion criteria: 1. Florid psychosis (mean positive symptoms <4 measured by PANSS) 2. Co-morbid neurological disorder 3. Substance dependence (not substance abuse) 4. IQ <70

Design outcomes

Primary

Measure	Time frame
Metacognitive functioning, which will be assessed using the Metacognitive Assessment Scale (MAS-NL) The post-treatment assessment is ten months after the baseline assessment; the follow-up assessment is six months after the post-treatment assessment.	—

Secondary

Measure	Time frame
1. Beck Depression Inventory (BDI-II) 2. Manchester Short Assessment of Quality of Life (MANSA) 3. Internalized Stigma of Mental Illness scale (ISMI) 4. Time Use 5. PSP and SF-12 (social functioning) 6. Positive and Negative Symptom Scale (PANSS) 7. Schedule for Assessment of Insight (SAI-E) Trailmaking Test A en B 8. Digit Symbol Task (WAIS I subtest) 9. Interpersonal Reactivity Index (IRI) 10. Faux Pas test 11. Empathic Accuracy Test 12. Work Readiness Questionnaire (WORQ) 13. Clinical Impression (CGI) 14. Care consumption list (zorgconsumptielijst) The post-treatment assessment is ten months after the baseline assessment; the follow-up assessment is six months after the post-treatment assessment.	—

Measure

Time frame

1. Beck Depression Inventory (BDI-II) 2. Manchester Short Assessment of Quality of Life (MANSA) 3. Internalized Stigma of Mental Illness scale (ISMI) 4. Time Use 5. PSP and SF-12 (social functioning) 6. Positive and Negative Symptom Scale (PANSS) 7. Schedule for Assessment of Insight (SAI-E) Trailmaking Test A en B 8. Digit Symbol Task (WAIS I subtest) 9. Interpersonal Reactivity Index (IRI) 10. Faux Pas test 11. Empathic Accuracy Test 12. Work Readiness Questionnaire (WORQ) 13. Clinical Impression (CGI) 14. Care consumption list (zorgconsumptielijst) The post-treatment assessment is ten months after the baseline assessment; the follow-up assessment is six months after the post-treatment assessment.

—

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 21, 2026